Recipharm, a global CDMO, has announced that it has extended its high potency offering at its Leganés site in Spain to GMP pilot scale, giving customers a single high containment route from development to commercial supply.
Vantage Nutrition, an ACG group company, will use SupplySide Global to highlight the evolving role of the nutraceutical CDMO in helping brands create differentiated, efficacious products that meet changing consumer demands.
Upperton has unveiled a new brand identity at CPHI Milan, marking a milestone in the company's evolution into an end-to-end CDMO focused on solving the challenges of molecule development across oral, nasal, pulmonary and parenteral dosage forms.
FUJIFILM Biotechnologies, a contract development and manufacturing organisation (CDMO) for biologics, vaccines, and advanced therapies, has announced its participation in CPHI 2026, taking place 6-8th October, in Milan, Italy.
Where are the biggest points of friction between drug development and commercial manufacturing today, and how can the industry remove them? FUJIFILM Biotechnologies, Systech and Pace Life Sciences discuss.
The BCMPA will show how specialist outsourcing partners bring a “touch of magic” to turn promising ideas into practical, scalable and market-ready products when it returns to London Packaging Week at ExceL London on 16-17th September 2026.
Bespak, an inhalation CDMO, has achieved a Gold EcoVadis sustainability rating for its Holmes Chapel site. The result places Bespak among the top 5% of companies assessed worldwide.
Kindeva, a drug delivery Contract Development and Manufacturing Organisation, has announced the appointment of Brok Weichbrodt as chief transformation officer to accelerate growth as the company enters the next phase of its value creation plan.
